Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Marsha Alpert Chandler Insider Profile
4 Followers
Marsha Alpert Chandler, Director at Biocept, holds 7.08K shares in Biocept (Ticker: BIOCQ). Most recently, Marsha Alpert Chandler Bought $2,000 shares of Biocept on Feb 17, 2015 for an estimated value of 2.50K.
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-43.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Marsha Alpert Chandler's holdings
Insider Roles
Director
Roles that Marsha Alpert Chandler holds in companies
Most Profitable Insider Trade
The most profitable trade made by Marsha Alpert Chandler
Marsha Alpert Chandler's Trading History
List of latest transactions for each holding click on a transaction to see Marsha Alpert Chandler's performance on stock
You May Also Like
Marsha Alpert Chandler insider profile FAQ
What is the percentage of profitable transactions made by Marsha Alpert Chandler?
The percentage of profitable transactions made by Marsha Alpert Chandler is 0%.
What is the average return per transaction made by Marsha Alpert Chandler?
The average return per transaction made by Marsha Alpert Chandler is -43.50%.
What stocks does Marsha Alpert Chandler hold?
Marsha Alpert Chandler holds: BIOCQ stocks.
What was Marsha Alpert Chandler’s latest transaction?
Marsha Alpert Chandler latest transaction was an Informative Buy of $2.50K.
What was Marsha Alpert Chandler's most profitable transaction?
Marsha Alpert Chandler’s most profitable transaction was an Informative Buy of BIOCQ stock on February 17, 2015. The return on the trade was -0.70%.
What is Marsha Alpert Chandler's role in Biocept?
Marsha Alpert Chandler's role in Biocept is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.